For example, in PAAD, SIRT1 mutations are negatively correlated with overall survival (59), whereas in BRCA, SIRT1 mutations are associated with increased tumor grade and lymph node metastasis (54). This evidence concerns the gene SIRT1 and metastatic malignant neoplasm in the lymph nodes.